Literature DB >> 24606476

Esophageal/gastric cancer screening in high-risk populations in Henan Province, China.

Yu-Fei Lu1, Zhi-Cai Liu, Zhong-Hong Li, Wen-Hao Ma, Fu-Rang Wang, Ya-Bing Zhang, Jian-Bang Lu.   

Abstract

OBJECTIVE: To summarize the endoscopic screening findings in high-risk population of esophageal and gastric carcinoma and analyze influential factors related to screening.
METHODS: In seven selected cities and counties with high incidences of esophageal carcinoma, people at age of 40-69 were set as the target population. Those with gastroscopy contradictions were excluded, and all who were voluntary and willing to comply with the medical requirements were subjected to endoscopic screening and histological examination for esophageal, gastric cardia and gastric carcinoma in accordance with national technical manual for early detection and treatment of cancer.
RESULTS: In three years, 36,154 people were screened, and 16,847 (46.60%) cases were found to have precancerous lesions. A total of 875 cases were found to have cancers (2.42%), and among them 739 cases had early stage with an early diagnosis rate is 84.5%. Some 715 patients underwent prompt treatment and the success rate was 81.8%.
CONCLUSIONS: In a high-risk population of esophageal and gastric carcinoma, it is feasible to implement early detection and treatment by endoscopic screening. Screening can identify potential invasive carcinoma, early stage carcinoma and precancerous lesions, improving efficacy through early detection and treatment. The exploratory analysis of related influential factors will help broad implementation of early detection and treatment for esophageal and gastric carcinoma.

Entities:  

Mesh:

Year:  2014        PMID: 24606476     DOI: 10.7314/apjcp.2014.15.3.1419

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  13 in total

Review 1.  Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries.

Authors:  María José Domper Arnal; Ángel Ferrández Arenas; Ángel Lanas Arbeloa
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

Review 2.  Barriers and Facilitators Associated with Delays in the Diagnosis and Treatment of Gastric Cancer: a Systematic Review.

Authors:  Afrooz Mazidimoradi; Zohre Momenimovahed; Hamid Salehiniya
Journal:  J Gastrointest Cancer       Date:  2021-09-09

Review 3.  Value of screening endoscopy in evaluation of esophageal, gastric and colon cancers.

Authors:  Tae H Ro; Michelle A Mathew; Subhasis Misra
Journal:  World J Gastroenterol       Date:  2015-09-07       Impact factor: 5.742

4.  MicroRNA-106b~25 expressions in tumor tissues and plasma of patients with gastric cancers.

Authors:  Rupeng Zhang; Weijia Wang; Fangxuan Li; Hui Zhang; Juntian Liu
Journal:  Med Oncol       Date:  2014-09-14       Impact factor: 3.064

5.  Histone demethylase KDM2A promotes tumor cell growth and migration in gastric cancer.

Authors:  Yufeng Huang; Yiqian Liu; Lijiang Yu; Jing Chen; Juan Hou; Lihua Cui; De Ma; Wangkun Lu
Journal:  Tumour Biol       Date:  2014-09-23

6.  Mortality reduction from gastric cancer by endoscopic and radiographic screening.

Authors:  Chisato Hamashima; Michiko Shabana; Katsuo Okada; Mikizo Okamoto; Yoneatsu Osaki
Journal:  Cancer Sci       Date:  2015-11-11       Impact factor: 6.716

7.  Massive Endoscopic Screening for Esophageal and Gastric Cancers in a High-Risk Area of China.

Authors:  Xianzhi Zheng; Xuhua Mao; Kun Xu; Lingshuang Lü; Xianzhen Peng; Min Wang; Guisheng Xu; Zhaolai Hua; Jianping Wang; Hengchuan Xue; Jianming Wang; Cheng Lu
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

Review 8.  Strategies for prevention of gastrointestinal cancers in developing countries: a systematic review.

Authors:  Ahmad Zia Shams; Ulrike Haug
Journal:  J Glob Health       Date:  2017-12       Impact factor: 4.413

9.  Cancer incidence and mortality in China, 2014.

Authors:  Wanqing Chen; Kexin Sun; Rongshou Zheng; Hongmei Zeng; Siwei Zhang; Changfa Xia; Zhixun Yang; He Li; Xiaonong Zou; Jie He
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087

10.  The Clinical Significance of MiR-429 as a Predictive Biomarker in Colorectal Cancer Patients Receiving 5-Fluorouracil Treatment.

Authors:  Sheng-Jian Dong; Xiao-Jun Cai; Shu-Jin Li
Journal:  Med Sci Monit       Date:  2016-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.